Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Research Group

Prostate and Urologic Cancer

Status

Active, not recruiting

NCT ID

NCT04300855

This randomized double-blinded Phase II clinical trial will evaluate the bioavailability, safety, effectiveness and validate the mechanism by which a standardized formulation of whole Green Tea Catechin, (Sunphenon® 90D) containing 405 mgs vs. Placebo, administered for 24 months in a cohort of men with low to intermediate grade prostate managed on active surveillance

Intervention

Placebo, Sunphenon

Condition

Prostate Cancer, Prostate Adenocarcinoma

Investigators

Nagi Kumar, PhD, RD, FADA

See list of participating sites